Pub. Date : 2021 Dec
PMID : 34533681
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | BACKGROUND: Docetaxel, carboplatin and trastuzumab, with or without pertuzumab (TCH(P)), has become the preferred (neo)adjuvant regimen for HER2-positive breast cancer. | thiocarbohydrazide | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |